Trial Profile
Clinical outcomes after sirolimus-eluting stent implantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions; Therapeutic Use
- 25 Feb 2016 New trial record